Related Compounds
Compounds connected by the same goals, effects, or research topics.
Compound Profile
Yohimbine
Yohimbine carries a Grade B rating — moderate evidence.
Review needed — Can cause hypertension, anxiety, tachycardia; contraindicated in cardiovascular disease. Details
Last reviewed: •1 source citedReport a correctionProfile-wide ·B Moderate
At a glance
From this profile's structured data- Evidence
- Grade B
- Safety
- Can cause hypertension, anxiety, tachycardia; contraindicated in cardiovascular disease.
- Profile context
- alpha-2 adrenergic receptor
Next stepsWhere to go next — guides & comparisons
Continue reading
- If you want to browse more compounds → All compounds
Quick stats
- Evidence level
- Moderate evidence
- Typical onset
- Varies by prep
- Safety rating
- Review needed: Safety review pending
- Best for
- Alpha 2 Adrenergic Receptor
- Avoid / review if
- Monoamine Oxidase Inhibitor Medications Due To Hypertensive Crisis Risk, Hypertension Or Other Cardiovascular Disease Including Recent Heart Attack Or Arrhythmia, Severe Kidney Or Liver Disease Reduces Clearance
Botanical Context
Source botanicals and comparison guides related to Yohimbine.
Safety
Safety & Cautions
Can cause hypertension, anxiety, tachycardia; contraindicated in cardiovascular disease.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
- Liver-SensitiveLiver-related caution language appears in the profile.
- Stimulant-Like ProfileStimulant-like or activating caution language is present.
Evidence-based safety
Caution when combined
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
High-Priority Caution
26 flagged pairingsSerotonergic activity
High-Priority Caution
26 flagged pairingsSerotonergic activity
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Serotonergic activityCertainty: Theoretical
Data provenance recorded for 26 of 26 pairings in this mechanism group.
- 5-HTP — Theoretical interaction certainty
- Caffeine — Theoretical interaction certainty
- crocetin — Theoretical interaction certainty
- crocin — Theoretical interaction certainty
- Crocus Sativus — Theoretical interaction certainty
- Damiana — Theoretical interaction certainty
- DMT — Theoretical interaction certainty
- Ginkgo — Theoretical interaction certainty
- Panax Red Ginseng — Theoretical interaction certainty
- Panax White Ginseng — Theoretical interaction certainty
- Harmaline — Theoretical interaction certainty
- Harmine — Theoretical interaction certainty
+14 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Moderate Caution
81 flagged pairingsBlood-pressure effects
Moderate Caution
81 flagged pairingsBlood-pressure effects
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Blood-pressure effectsCertainty: Theoretical
Data provenance recorded for 81 of 81 pairings in this mechanism group.
- Agmatine sulfate — Theoretical interaction certainty
- ajoene — Theoretical interaction certainty
- Allicin — Theoretical interaction certainty
- American Ginseng Extract — Theoretical interaction certainty
- Andrographis — Theoretical interaction certainty
- Angelica Dahurica — Theoretical interaction certainty
- Astaxanthin — Theoretical interaction certainty
- Astragalus Membranaceus — Theoretical interaction certainty
- Beetroot extract — Theoretical interaction certainty
- Berberis — Theoretical interaction certainty
- Bicarbonate — Theoretical interaction certainty
- Black Seed — Theoretical interaction certainty
+69 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence Summary
Profile-wide ·B ModerateEvidence lens
Useful signal, but study design, dose, and population still matter.
ModerateModerate evidence
Human clinical evidence: Not the primary signal
Mechanistic / preclinical: Mechanism mapped — Metabolic Regulation · Vascular Function Support · Adrenergic
Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.
Safety boundary: Safety note available — Can cause hypertension, anxiety, tachycardia; contraindicated in cardiovascular disease.
This profile cites 1 human study.
Evidence Strength
Confidence estimate based on the design quality and consistency of published clinical trials.
Yohimbine has a moderate evidence rating.
General wellnessGeneral wellness
Citation density
1.0
Sources
1
Effects
1
Research recency
Mixed recency
Evidence Grade
Grade B: Moderate Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Meta analysis
- Risk of Bias
- Low
- Consistency
- Not assessed
Strongest recorded design is a meta analysis, drawn from 1 recorded study, 1 in people.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (1)0 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable
What the evidence actually shows
This table contains 1 structured source, including 0 human evidence sources; 0 are human trials. A reliable participant total cannot be calculated because sample size is not consistently structured in the cited sources. Source-to-conclusion relationships are not classified in this structured set, so consistency is not yet classifiable.
Profile-wide evidence grade: see the profile grade above · Confidence: not separately assigned
What would change our conclusion?
Larger, well-controlled human trials using comparable populations, doses, preparations, and clinically meaningful outcomes could materially strengthen or weaken this conclusion. Replication in a different population or a high-quality synthesis resolving current disagreement could also materially change confidence.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis PubMed · Turk J Urol · 2021 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | PubMed → |
How Yohimbine Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Yohimbine Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Dosing
- Common form
- capsule
- No standardized dose
- Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
- Metabolic Regulation
- Vascular Function Support
- Adrenergic
- Metabolic
Guides that use Yohimbine
Condition guides
Continue exploring
Related research paths
Related Herbs
Botanicals connected by the same goals, effects, or research topics.
Related Guides
Deeper context, comparisons, and practical research paths.
Related Safety Pages
Safety checks and cautions relevant to this decision.
Related Articles
Deeper context, comparisons, and practical research paths.
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Related alternatives
Herbs for similar conditions
Tradeoffs
Free safety checklist
Get the Yohimbine evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Compound profile context
How to interpret Yohimbine
Yohimbine compound profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Yohimbine, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.